PD Dr. med. Yasmin Schmid

Schuldt, Anna, Clark, Ian C., Schmid, Yasmin, Ljuslin, Michael, Boehlke, Christopher, Schipper, Sivan, Sands, Megan B., & Blum, David. (2025). Psychedelic-Assisted Therapy in Palliative Care—Insights from an International Workshop. Healthcare, 13(18), 2275. https://doi.org/https://doi.org/10.3390/healthcare13182275

Ley, Laura, Liechti, Matthias E., Becker, Anna M., Straumann, Isabelle, Klaiber, Aaron, Holze, Friederike, Vogt, Severin B., Arikci, Denis, & Schmid, Yasmin. (2025). Motivation and retrospective appraisal of psychedelic study participation: a qualitative study in healthy volunteers [Journal-article]. Psychopharmacology, 242, 1875–1892. https://doi.org/10.1007/s00213-025-06772-4

Christen, S. E., Bekka, E., Schmid, Y., Benowitz, N. L., & Liakoni, E. (2025). Caffeine, nicotine, cannabis, and psilocybin: Pharmacology, toxicology, and potential therapeutic uses of four naturally occurring psychoactive substances [Journal-article]. Swiss Medical Weekly, 155(7), 4346. https://doi.org/10.57187/s.4346

Mueller, Lorenz, Santos de Jesus, Joyce, Schmid, Yasmin, Müller, Felix, Becker, Anna, Klaiber, Aaron, Straumann, Isabelle, Luethi, Dino, Haijen, Eline CHM, Hurks, Petra PM, Kuypers, Kim PC, & Liechti, Matthias E. (2025). Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults: A Randomized Clinical Trial. JAMA Psychiatry, 82(6), 555–562. https://doi.org/10.1001/jamapsychiatry.2025.0044

Noback, M., Kenton, J. A., Klein, A. K., Hughes, Z. A., Kruegel, A. C., Schmid, Y., Halberstadt, A. L., & Young, J. W. (2025). Low (micro)doses of 2,5-dimethoxy-4-propylamphetamine (DOPR) increase effortful motivation in low-performing mice [Journal-article]. Neuropharmacology, 268, 110334. https://doi.org/10.1016/j.neuropharm.2025.110334

Liechti, Matthias E., Gasser, Peter, Aicher, Helena D., Mueller, Felix, Hawrot, Tadeusz, & Schmid, Yasmin. (2025). Implementing psychedelic-assisted therapy: History and characteristics of the Swiss limited medical use program [Journal-article]. Neuroscience Applied, 4. https://doi.org/10.1016/j.nsa.2025.105525

Mueller, L., Klaiber, A., Ley, L., Becker, A. M., Thomann, J., Luethi, D., Schmid, Y., & Liechti, M. E. (2025). Pharmacokinetics, Pharmacodynamics, and Urinary Recovery of Oral Mescaline Hydrochloride in Healthy Participants [Journal-article]. Clinical Pharmacokinetics. https://doi.org/10.1007/s40262-025-01544-x

Ouwerkerk, Joep J J, Wood, David M, Dines Alison M, Yates Christopher, Eyer, Florian, Heyerdahl, Fridtjof, Giraudon, Isabelle, Hovda, Knut Erik, Liechti Matthias E, Miró, Òscar, Vallersnes, Odd Martin, Dargan, Paul I, Euro-DEN Plus Research Group, F M J Gresnigt 1 14, & Euro-DEN Plus research group authors: (2025). Differences in the clinical presentation of acute 3,4-methylenedioxymetamfetamine intoxication by co-intoxication and patient sex to European emergency departments. Clinical Toxicology, 63(3), 183–192. https://doi.org/10.1080/15563650.2025.2453052

Williams, Martin L., Rudin, Deborah, Schmid, Yasmin, & von Salm, Jacqueline. (2025). Editorial: Beyond psilocybin: exploring the clinical potential of alternative and novel psychedelics. Frontiers in Psychiatry, 16. https://doi.org/10.3389/fpsyt.2025.1600812

Klaiber, A., Schmid, Y., Becker, A. M., Straumann, I., Erne, L., Jelusic, A., Thomann, J., Luethi, D., & Liechti, M. E. (2024). Acute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects [Journal-article]. Translational Psychiatry, 14(1). https://doi.org/10.1038/s41398-024-03116-2

Vizeli, Patrick, Studerus, Erich, Holze, Friederike, Schmid, Yasmin, Dolder, Patrick C., Ley, Laura, Straumann, Isabelle, Becker, Anna M., Müller, Felix, Arikci, Denis, & Liechti, Matthias E. (2024). Pharmacological and non-pharmacological predictors of the LSD experience in healthy participants. Translational Psychiatry, 14(1). https://doi.org/10.1038/s41398-024-03074-9

Schipper, Sivan, Nigam, Kabir, Schmid, Yasmin, Piechotta, Vanessa, Ljuslin, Michael, Beaussant, Yvan, Schwarzer, Guido, & Boehlke, Christopher. (2024). Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases. Cochrane Database of Systematic Reviews, 2024(9). https://doi.org/10.1002/14651858.CD015383.pub2

Angerer, Verena, Schmid, Yasmin, Franz, Florian, Gnann, Heike, Speer, Jan Manuel, Gnann, Anke, Helmecke, Stephan, Buchwald, Armin, Brandt, Simon D., Passie, Torsten, Liechti, Matthias E., & Auwärter, Volker. (2024). Acute psychotropic, autonomic, and endocrine effects of 5,6-methylenedioxy-2-aminoindane (MDAI) compared with 3,4-methylenedioxymethamphetamine (MDMA) in human volunteers: A self-administration study. Drug Testing and Analysis, 16(9), 1002–1011. https://doi.org/10.1002/dta.3622

Schmid, Yasmin, & Bershad, Anya K. (2024). Altered States and Social Bonds: Effects of MDMA and Serotonergic Psychedelics on Social Behavior as a Mechanism Underlying Substance-Assisted Therapy [Journal-article]. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 9(5), 490–499. https://doi.org/10.1016/j.bpsc.2024.02.001

Aicher, H.D., Schmid, Y., & Gasser, P. (2024). Psychedelics-assisted psychotherapy: Experiences with the limited medical use of LSD, MDMA, and psilocybin in Switzerland. Psychotherapie, null. https://doi.org/10.1007/s00278-024-00711-y

Klaiber, Aaron, Humbert-Droz, Mélusine, Ley, Laura, Schmid, Yasmin, & Liechti, Matthias E. (2024). Safety pharmacology of acute mescaline administration in healthy participants. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16349

Waters, Mitchell L, Dargan, Paul I, Yates, Christopher, Dines, Alison M, Eyer, Florian, Giraudon, Isabelle, Heyerdahl, Fridtjof, Hovda, Knut Erik, Liechti, Matthias E, Miró, Òscar, Vallersnes, Odd Martin, Anseeuw, Kurt, Badaras, Robertas, Bitel, Marcin, Bonnici, Jeffrey, Brvar, Miran, Caganova, Blazena, Calýskan, Feriyde, Ceschi, Alessandro, et al. (2024). Clinical effects of cannabis compared to synthetic cannabinoid receptor agonists (SCRAs): a retrospective cohort study of presentations with acute toxicity to European hospitals between 2013 and 2020. Clinical Toxicology, 62(6), 378–384. https://doi.org/10.1080/15563650.2024.2346125

Stucky S, Müller O, Schmid Y, & Leuppi-Taegtmeyer A. (2023). Krampfanfall nach schwerer Asthmaexazerbation (No. 23; Vol. 22, pp. 1092–1094). https://doi.org/10.4414/smf.2023.09090

Vallersnes, O. M., Dines, A. M., Wood, D. M., Heyerdahl, F., Hovda, K. E., Yates, C., Giraudon, I., Caganova, B., Ceschi, A., Galicia, M., Liakoni, E., Liechti, M. E., Miró, Ò., Noseda, R., Persett, P. S., Põld, K., Schmid, Y., Scholz, I., Vigorita, F., & Dargan, P. I. (2023). Self-discharge during treatment for acute recreational drug toxicity: an observational study from emergency departments in seven European countries. International Journal of Emergency Medicine, 16(1). https://doi.org/10.1186/s12245-023-00566-1

Lewis V, Bonniwell EM, Lanham JK, Ghaffari A, Sheshbaradaran H, Cao AB, Calkins MM, Bautista-Carro MA, Arsenault E, Telfer A, Taghavi-Abkuh FF, Malcolm NJ, El Sayegh F, Abizaid A, Schmid Y, Morton K, Halberstadt AL, Aguilar-Valles A, & McCorvy JD. (2023). A non-hallucinogenic LSD analog with therapeutic potential for mood disorders. Cell Reports, 42(3), 112203. https://doi.org/10.1016/j.celrep.2023.112203

Miró, Òscar, Burillo-Putze, Guillermo, Schmid, Yasmin, Salgado, Emilio, Liechti, Matthias E., Dines, Alison M., Giraudon, Isabelle, Heyerdahl, Fridtjof, Hovda, Knut Erik, Vallersne, Odd Martin, Eyer, Florian, Wood, David M., Yates, Christopher, Dargan, Paul I., Galicia, Miguel, & Euro-DEN Plus Research Group. (2023). Severity of emergency department presentations due to acute drug toxicity in Europe: A longitudinal analysis over a 6-year period (2014-2019) stratified by sex. European Journal of Emergency Medicine, 30(1), 21–31. https://doi.org/10.1097/MEJ.0000000000000978

Halberstadt A, Schmid Y, Bonniwell E, Lanham J, Ghaffari A, Coo A, Sheshbaradaran H, & McCorvy J. (2022). Investigation of the Pharmacological Properties of 2-Br-LSD, a Non-Hallucinogenic LSD Analog. 47, 264–265. https://doi.org/https://doi.org/10.1038/s41386-022-01485-0

Dongre, Kanchan, Schmid, Yasmin, Nussbaum, Luana, Winterhalder, Clemens, Bassetti, Stefano, Holbro, Andreas, Degen, Lukas, & Leuppi-Taegtmeyer, Anne B. (2022). Gastrointestinal bleeding during anticoagulation with direct oral anticoagulants compared to vitamin K antagonists. Global Cardiology Science and Practice, 2022(3). https://doi.org/10.21542/gcsp.2022.21

Heier, Eva-Carina, Eyer, Florian, Rabe, Christian, Geith, Stefanie, Dargan, Paul I., Wood, David M., Heyerdahl, Fridtjof, Dines, Alison M., Giraudon, Isabelle, Erik Hovda, Knut, Yates, Chris, Vallersnes, Odd Martin, Miró, Òscar, Liechti, Matthias E., Zellner, Tobias, Anand, Lukasz, Waldman, Wojciech, Anseeuw, Kurt, Gillebeert, Johan, et al. (2022). Clinical effect of ethanol co-use in patients with acute drug toxicity involving the use of central nervous system depressant recreational drugs. European Journal of Emergency Medicine, 29(4), 291–300. https://doi.org/10.1097/MEJ.0000000000000932

Müller, Felix, Kraus, Elias, Holze, Friederike, Becker, Anna, Ley, Laura, Schmid, Yasmin, Vizeli, Patrick, Liechti, Matthias E., & Borgwardt, Stefan. (2022). Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants. Psychopharmacology, 239(6), 1933–1943. https://doi.org/10.1007/s00213-022-06066-z

Schmid Y, Galicia M, Vogt SB, Liechti ME, Burillo-Putze G, Dargan PI, Dines A, Giraudon I, Heyerdahl F, Hovda KE, Wood DM, Yates C, & Miró O. (2022). Age- and sex-related differences in clinical presentations due to acute cannabis toxicity at European Emergency Departments. Clinical Toxicology, 60(S1), 13–14. https://doi.org/doi.org/10.1080/15563650.2022.2054576

Schmid Y, Galicia M, Vogt SB, Liechti ME, Burillo-Putze G, Dargan PI, Dines AM, Giraudon I, Heyerdahl F, Hovda KE, Wood DM, Yates C, Miró Ò, & (on behalf of the Euro-DEN Plus Research Group). (2022). Differences in clinical features associated with cannabis intoxication in presentations to European emergency departments according to patient age and sex. Clinical Toxicology, 60(8), 912–919. https://doi.org/10.1080/15563650.2022.2060116

Layne KA, Dargan PI, Dines AM, Leaper C, Yates C, Hovda KE, Heyerdahl F, Archer JRH, Giraudon I, Wood DM, & Euro-DEN Plus Research Group. (2021). Acute toxicity related to misuse (nonmedical use) of tramadol: Experience of the European Drug Emergencies Network Plus. British Journal of Clinical Pharmacology, 87(4), 1668–1675. https://doi.org/10.1111/bcp.14408

Schmid, Yasmin, Gasser, Peter, Oehen, Peter, & Liechti, Matthias E. (2021). Acute subjective effects in LSD- and MDMA-assisted psychotherapy. Journal of Psychopharmacology, 35(4), 362–374. https://doi.org/10.1177/0269881120959604

Noseda, Roberta, Schmid, Yasmin, Scholz, Irene, Liakoni, Evangelia, Liechti, Matthias E, Dargan, Paul I, Wood, David M, Dines, Alison M, Yates, Christopher, Heyerdahl, Fridtjof, Hovda, Knut E, Giraudon, Isabelle, Ceschi, Alessandro, & Euro-DEN Research Group. (2021). MDMA-related presentations to the emergency departments of the European Drug Emergencies Network plus (Euro-DEN Plus) over the four-year period 2014-2017. Clinical Toxicology (Philadelphia, Pa.), 59(2), 131–137. https://doi.org/10.1080/15563650.2020.1784914

Noseda R, Schmid Y, Scholz I, Liakoni E, Liechti ME, Dargan PI, Wood DM, Dines AM, Yates C, Heyerdahl F, Hovda KE, Giraudon I, Ceschi A, & Euro-DEN Research Group. (2021). MDMA-related presentations to the emergency departments of the European Drug Emergencies Network plus (Euro-DEN Plus) over the four-year period 2014-2017. Clinical Toxicology (Philadelphia, Pa.), 59(2), 131–137. https://doi.org/10.1080/15563650.2020.1784914

Istampoulouoglou I, & Schmid Y. (2021). SOP Paracetamolintoxikation (Patent No. 3). 3, Article 3. Thieme.

Vizeli, Patrick, Straumann, Isabelle, Holze, Friederike, Schmid, Yasmin, Dolder, Patrick C., & Liechti, Matthias E. (2021). Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis. Scientific Reports, 11(1), 10851. https://doi.org/10.1038/s41598-021-90343-y

Schmid Y. (2020, January 1). Psychedelika in der Behandlung von Cluster-Kopfschmerzen.

Schmid, Yasmin, Scholz, Irene, Mueller, Laura, Exadaktylos, Aristomenis K., Ceschi, Alessandro, Liechti, Matthias E., & Liakoni, Evangelia. (2020). Emergency department presentations related to acute toxicity following recreational use of cannabis products in Switzerland. Drug and Alcohol Dependence, 206, 107726. https://doi.org/10.1016/j.drugalcdep.2019.107726

Suenderhauf, Claudia, Berger, Benjamin, Puchkov, Maxim, Schmid, Yasmin, Müller, Sabine, Huwyler, Jörg, Haschke, Manuel, Krähenbühl, Stephan, & Duthaler, Urs. (2020). Pharmacokinetics and phenotyping properties of the “Basel” phenotyping cocktail combination capsule in healthy male adults. British Journal of Clinical Pharmacology, 86(2), 352–361. https://doi.org/10.1111/bcp.14157

Bühler T, Schmid Y, & Liechti ME. (2019). [Knockout Drugs: Diagnostics in the Emergency Unit and Clinical Practice]. Praxis, 108(13), 869–876. https://doi.org/10.1024/1661-8157/a003306

Wolfe CE, Wood DM, Dines A, Whatley BP, Yates C, Heyerdahl F, Hovda KE, Giraudon I, Dargan PI, & Euro-DEN Research Group. (2019). Seizures as a complication of recreational drug use: Analysis of the Euro-DEN Plus data-set. NeuroToxicology, 73, 183–187. https://doi.org/10.1016/j.neuro.2019.04.003

Brockhaus L, Schmid Y, Rast AC, Rätz Bravo AE, Hofmeier KS, & Leuppi-Taegtmeyer AB. (2019). Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: Case report and review of the literature including WHO spontaneous safety reports. BMC Pharmacology and Toxicology, 20(1), 9. https://doi.org/10.1186/s40360-019-0289-7

Bühler, Tim, Schmid, Yasmin, & Liechti, Matthias E. (2019). Verdacht auf K.o.-Mittel: Diagnostik in der Notfallstation und Praxis. Praxis, 108(13), 869–876. https://doi.org/10.1024/1661-8157/a003306

Kiene, Klara, Hayasi, Noriyuki, Burhenne, Jürgen, Uchitomi, Ryo, Sünderhauf, Claudia, Schmid, Yasmin, Haschke, Manuel, Haefeli, Walter Emil, Krähenbühl, Stephan, Mikus, Gerd, Inada, Hirohiko, & Huwyler, Jörg. (2019). Microdosed midazolam for the determination of cytochrome P450 3A activity: Development and clinical evaluation of a buccal film. European Journal of Pharmaceutical Sciences, 135, 77–82. https://doi.org/10.1016/j.ejps.2019.05.010

Leuppi-Taegtmeyer, Anne, Duthaler, Urs, Hammann, Felix, Schmid, Yasmin, Dickenmann, Michael, Amico, Patricia, Jehle, Andreas W., Kalbermatter, Stefan, Lenherr, Christoph, Meyer Zu Schwabedissen, Henriette E., Haschke, Manuel, Liechti, Matthias E., & Krähenbühl, Stephan. (2019). Pharmacokinetics of oxycodone/naloxone and its metabolites in patients with end-stage renal disease during and between haemodialysis sessions. Nephrology, Dialysis, Transplantation, 34(4), 692–702. https://doi.org/10.1093/ndt/gfy285

Schmid, Yasmin, Navarini, Alexander, Manjaly Thomas, Zita-Rose, Pfleiderer, Bettina, Krähenbühl, Stephan, & Mueller, Simon M. (2019). Sex differences in the pharmacology of itch therapies - a narrative review. Current Opinion in Pharmacology, 46, 122–142. https://doi.org/10.1016/j.coph.2019.05.008

Scholz, Irene, Schmid, Yasmin, Exadaktylos, Aristomenis K., Haschke, Manuel, Liechti, Matthias E., & Liakoni, Evangelia. (2019). Emergency department presentations related to abuse of prescription and over-the-counter drugs in Switzerland: time trends, sex and age distribution. Swiss Medical Weekly, 149, w20056. https://doi.org/10.4414/smw.2019.20056

Boxler, Martina I., Streun, Gabriel L., Liechti, Matthias E., Schmid, Yasmin, Kraemer, Thomas, & Steuer, Andrea E. (2018). Human Metabolome Changes after a Single Dose of 3,4-Methylenedioxymethamphetamine (MDMA) with Special Focus on Steroid Metabolism and Inflammation Processes. Journal of proteome research, 17(8), 2900–2907. https://doi.org/10.1021/acs.jproteome.8b00438

Dolder, Patrick C., Müller, Felix, Schmid, Yasmin, Borgwardt, Stefan J., & Liechti, Matthias E. (2018). Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects. Psychopharmacology, 235(2), 467–479. https://doi.org/10.1007/s00213-017-4650-5

Schmidt, A., Müller, F., Lenz, C., Dolder, P. C., Schmid, Y., Zanchi, D., Lang, U. E., Liechti, M. E., & Borgwardt, S. (2018). Acute LSD effects on response inhibition neural networks. Psychological Medicine, 48(9), 1464–1473. https://doi.org/10.1017/s0033291717002914

Schmidt, André, Müller, Felix, Dolder, Patrick C., Schmid, Yasmin, Zanchi, Davide, Egloff, Laura, Liechti, Matthias E., & Borgwardt, Stefan. (2018). Acute Effects of Methylphenidate, Modafinil, and MDMA on Negative Emotion Processing. The International Journal of Neuropsychopharmacology, 21(4), 345–354. https://doi.org/10.1093/ijnp/pyx112

Schmid, Yasmin, & Liechti, Matthias E. (2018). Long-lasting subjective effects of LSD in normal subjects. Psychopharmacology, 235(2), 535–545. https://doi.org/10.1007/s00213-017-4733-3

Liechti ME, Schmid Y, Rentsch KM, Hammann F, & Dolder PC. (2017). Pharmacokinetics and pharmacodynamics of two doses of oral LSD in healthy subjects. (Patent No. 5). 55(5), Article 5. https://www.tandfonline.com/doi/abs/10.1080/15563650.2017.1309792

Vizeli P, Schmid Y, & Liechti ME. (2017). Pharmacogenetics of 3,4-methylenedioxymethamphetamine (MDMA): cytochrome P450 polymorphisms moderate pharmacokinetics and pharmacodynamic effects of MDMA in healthy subjects. (Patent No. 5). 55(5), Article 5. https://doi.org/doi.org/10.1080/15563650.2017.1309792

Boxler, Martina I, Liechti, Matthias E, Schmid, Yasmin, Kraemer, Thomas, & Steuer, Andrea E. (2017). First Time View on Human Metabolome Changes after a Single Intake of 3,4-Methylenedioxymethamphetamine in Healthy Placebo-Controlled Subjects. Journal of Proteome Research, 16(9), 3310–3320. https://doi.org/10.1021/acs.jproteome.7b00294

Boxler MI, Liechti ME, Schmid Y, Kraemer T, & Steuer AE. (2017). First Time View on Human Metabolome Changes after a Single Intake of 3,4-Methylenedioxymethamphetamine in Healthy Placebo-Controlled Subjects. Journal of Proteome Research, 16(9), 3310–3320. https://doi.org/10.1021/acs.jproteome.7b00294

Vizeli, P., Schmid, Y., & Liechti, M. (2017). Cytochrome P450 polymorphisms moderate pharmacokinetics and pharmacodynamic effects of MDMA in healthy subjects [Journal-article]. European Neuropsychopharmacology, 27, S61–S62. https://doi.org/10.1016/s0924-977x(17)30133-5

Dolder, Patrick C., Holze, Friederike, Liakoni, Evangelia, Harder, Samuel, Schmid, Yasmin, & Liechti, Matthias E. (2017). Alcohol acutely enhances decoding of positive emotions and emotional concern for positive stimuli and facilitates the viewing of sexual images. Psychopharmacology, 234(1), 41–51. https://doi.org/10.1007/s00213-016-4431-6

Dolder, Patrick C., Schmid, Yasmin, Steuer, Andrea E., Kraemer, Thomas, Rentsch, Katharina M., Hammann, Felix, & Liechti, Matthias E. (2017). Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects. Clinical Pharmacokinetics, 56(10), 1219–1230. https://doi.org/10.1007/s40262-017-0513-9

Liechti, Matthias E., Dolder, Patrick C., & Schmid, Yasmin. (2017). Alterations of consciousness and mystical-type experiences after acute LSD in humans. Psychopharmacology, 234(9-10), 1499–1510. https://doi.org/10.1007/s00213-016-4453-0

Müller, F., Lenz, C., Dolder, P. C., Harder, S., Schmid, Y., Lang, U. E., Liechti, M. E., & Borgwardt, S. (2017). Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects. Translational Psychiatry, 7(4), e1084. https://doi.org/10.1038/tp.2017.54

Schmidt, André, Müller, Felix, Dolder, Patrick C., Schmid, Yasmin, Zanchi, Davide, Liechti, Matthias E., & Borgwardt, Stefan. (2017). Comparative Effects of Methylphenidate, Modafinil, and MDMA on Response Inhibition Neural Networks in Healthy Subjects. International Journal of Neuropsychopharmacology, 20(9), 712–720. https://doi.org/10.1093/ijnp/pyx037

Steuer, Andrea E., Poetzsch, Michael, Stock, Lorena, Eisenbeiss, Lisa, Schmid, Yasmin, Liechti, Matthias E., & Kraemer, Thomas. (2017). Development and validation of an ultra-fast and sensitive microflow liquid chromatography-tandem mass spectrometry (MFLC-MS/MS) method for quantification of LSD and its metabolites in plasma and application to a controlled LSD administration study in humans. Drug Testing and Analysis, 9(5), 788–797. https://doi.org/10.1002/dta.2042

Vizeli, Patrick, Schmid, Yasmin, Prestin, Katharina, Meyer Zu Schwabedissen, Henriette E., & Liechti, Matthias E. (2017). Pharmacogenetics of ecstasy: CYP1A2, CYP2C19, and CYP2B6 polymorphisms moderate pharmacokinetics of MDMA in healthy subjects. European Neuropsychopharmacology, 27(3), 232–238. https://doi.org/10.1016/j.euroneuro.2017.01.008

Dolder PC, Schmid Y, Borgwardt SJ, Rentsch KM, & Liechti ME. (2016). Acute dose-response of LSD in healthy subjects (Patent No. S2). 26(S2), Article S2.

Dolder, P. C., Schmid, Y., Mueller, F., Borgwardt, S., & Liechti, M. E. (2016). LSD acutely impairs fear recognition and enhances emotional empathy and sociality [Journal-article]. European Neuropsychopharmacology, 26, S261. https://doi.org/10.1016/s0924-977x(16)31139-7

Dolder, P. C., Schmid, Y., Mueller, F., Borgwardt, S., Rentsch, K. M., & Liechti, M. E. (2016). Acute dose-response effects of LSD in healthy humans [Journal-article]. European Neuropsychopharmacology, 26, S248–S249. https://doi.org/10.1016/s0924-977x(16)31119-1

Liechti, M. E., Schmid, Y., Dolder, P. C., & Hysek, C. M. (2016). Effects of MDMA on social cognition [Journal-article]. European Neuropsychopharmacology, 26, S145–S146. https://doi.org/10.1016/s0924-977x(16)30949-x

Schmid, Y., Vizeli, P., Hysek, C., Prestin, K., zu Schwabedissen, H. Meyer, & Liechti, M. (2016). Cytochrome 2D6 function moderates the pharmacokinetics and pharmacodynamics of MDMA in healthy subjects [Journal-article]. European Neuropsychopharmacology, 26, S179–S180. https://doi.org/10.1016/s0924-977x(16)31010-0

Dolder, Patrick C., Schmid, Yasmin, Müller, Felix, Borgwardt, Stefan, & Liechti, Matthias E. (2016). LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality. Neuropsychopharmacology, 41(11), 46–2638. https://doi.org/10.1038/npp.2016.82

Schmid, Yasmin, Vizeli, Patrick, Hysek, Cédric M., Prestin, Katharina, Meyer Zu Schwabedissen, Henriette E., & Liechti, Matthias E. (2016). CYP2D6 function moderates the pharmacokinetics and pharmacodynamics of 3,4-methylene-dioxymethamphetamine in a controlled study in healthy individuals. Pharmacogenetics and Genomics, 26(8), 397–401. https://doi.org/10.1097/fpc.0000000000000231

Schmid Y, Vizeli P, Hysek CM, Prestin K, Meyer zu Schwabedissen HE, & Liechti ME. (2016). CYP2D6 function moderates the pharmacokinetics and pharmacodynamics of MDMA in a controlled study in healthy subjects (Patent No. S2). 26(S2), Article S2.

Steuer, Andrea E., Schmidhauser, Corina, Tingelhoff, Eva H., Schmid, Yasmin, Rickli, Anna, Kraemer, Thomas, & Liechti, Matthias E. (2016). Impact of cytochrome P450 2D6 function on the chiral blood plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA) and its phase I and II metabolites in humans. PLoS ONE, 11(3), e0150955. https://doi.org/10.1371/journal.pone.0150955

Strajhar, Petra, Schmid, Y., Liakoni, E., Dolder, P. C., Rentsch, K. M., Kratschmar, Denise V., Odermatt, Alex, & Liechti, Matthias E. (2016). Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects. Journal of Neuroendocrinology, 28(3), 12374. https://doi.org/10.1111/jne.12374

Dolder PC, Schmid Y, Rentsch K, & Liechti ME. (2015). Pharmacology of LSD in humans. (Patent No. 29). 29, Article 29.

Dolder, Patrick C, Schmid, Yasmin, Haschke, Manuel, Rentsch, Katharina M, & Liechti, Matthias E. (2015). Pharmacokinetics and concentration-effect relationship of oral LSD in humans. International journal of neuropsychopharmacology, 19(1), pyv072. https://doi.org/10.1093/ijnp/pyv072

Schmid, Yasmin, Enzler, Florian, Gasser, Peter, Grouzmann, Eric, Preller, Katrin H., Vollenweider, Franz X., Brenneisen, Rudolf, Müller, Felix, Borgwardt, Stefan, & Liechti, Matthias E. (2015). Acute effects of lysergic acid diethylamide in healthy subjects. Biological Psychiatry, 78(8), 53–544. https://doi.org/10.1016/j.biopsych.2014.11.015

Schmid, Yasmin, Hysek, Cédric M, Preller, Katrin H, Bosch, Oliver G, Bilderbeck, Amy C, Rogers, Robert D, Quednow, Boris B, & Liechti, Matthias E. (2015). Effects of methylphenidate and MDMA on appraisal of erotic stimuli and intimate relationships. European Neuropsychopharmacology, 25(1), 17–25. https://doi.org/10.1016/j.euroneuro.2014.11.020

Schmid, Yasmin, Rickli, Anna, Schaffner, Antonia, Duthaler, Urs, Grouzmann, Eric, Hysek, Cédric M., & Liechti, Matthias E. (2015). Interactions between bupropion and 3,4-methylenedioxymethamphetamine in healthy subjects. Journal of Pharmacology and Experimental Therapeutics, 353(1), 102–111. https://doi.org/10.1124/jpet.114.222356

Schmid Y, Dolder PC, & Liechti ME. (2015). Acute autonomic and psychotropic effects of LSD in healthy subject in a placebo-controlled study (Patent No. 4). 53(4), Article 4. https://doi.org/doi: 10.3109/15563650.2015.1024953

Steuer, Andrea E., Schmidhauser, Corina, Schmid, Yasmin, Rickli, Anna, Liechti, Matthias E., & Kraemer, Thomas. (2015). Chiral plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine and its phase I and II metabolites following controlled administration to humans. Drug metabolism and disposition, 43(12), 1864–1871. https://doi.org/10.1124/dmd.115.066340

Schmid, Y., Quednow, B.B., & Liechti, M.E. (2014, October 18). Effects of methylphenidate and MDMA (ecstasy) on appraisal of erotic stimuli [Journal-article]. In European Neuropsychopharmacology. Elsevier B.V. https://doi.org/10.1016/s0924-977x(14)71117-4

Hysek, C. M., Schmid, Y., Simmler, L. D., Domes, G., Heinrichs, M., Eisenegger, C., Preller, K. H., Quednow, B. B., & Liechti, M. E. (2014). MDMA enhances emotional empathy and prosocial behavior. Social cognitive and affective neuroscience, 9(11), 52–1645. https://doi.org/10.1093/scan/nst161

Hysek, C. M., Simmler, L. D., Schillinger, N., Meyer, N., Schmid, Y., Donzelli, M., Grouzmann, E., & Liechti, M. E. (2014). Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination. International journal of neuropsychopharmacology, 17(3), 81–371. https://doi.org/10.1017/s1461145713001132

Schmid, Yasmin, Hysek, Cédric M., Simmler, Linda D., Crockett, Molly J., Quednow, Boris B., & Liechti, Matthias E. (2014). Differential effects of MDMA and methylphenidate on social cognition. Journal of Psychopharmacology, 28(9), 56–847. https://doi.org/10.1177/0269881114542454

Schmid Y, Hysek CM, & Liechti ME. (2014). Acute effects of methylphenidate in healthy subjects alone and in combination with MDMA (Patent No. 4). 52(4), Article 4. https://doi.org/doi.org/10.3109/15563650.2014.906213

Schmid Y, Quednow BB, & Liechti ME. (2014, January 1). Effects of methylphenidate and MDMA (ecstasy) on appraisal of erotic stimuli. https://doi.org/ DOI: 10.1016/S0924-977X(14)71117-4

Seibert, Julia, Hysek, Cédric M., Penno, Carlos A., Schmid, Yasmin, Kratschmar, Denise V., Liechti, Matthias E., & Odermatt, Alex. (2014). Acute Effects of 3,4-Methylenedioxymethamphetamine and Methylphenidate on Circulating Steroid Levels in Healthy Subjects. Neuroendocrinology, 100(1), 17–25. https://doi.org/10.1159/000364879

Hysek, Cédric M, Schmid, Yasmin, Rickli, Anna, & Liechti, Matthias E. (2013). Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans : lost in translation. British journal of pharmacology, 170(6), 5–1273. https://doi.org/10.1111/bph.12398

Hysek, C., Schmid, Y., Rickli, A., Simmler, L. D., Donzelli, M., Grouzmann, E., & Liechti, M. E. (2012). Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans. British Journal of Pharmacology, 166(8), 88–2277. https://doi.org/10.1111/j.1476-5381.2012.01936.x